Table: begin end state 1 29 signal peptide 30 313 non-cytoplasmic 314 336 transmembrane 337 347 cytoplasmic 348 369 transmembrane 370 374 non-cytoplasmic 375 395 transmembrane 396 442 cytoplasmic 443 456 transmembrane 457 472 cytoplasmic 473 494 transmembrane 495 515 non-cytoplasmic
Input: >WP_012468821.1 NCBI__GCF_000020385.1:WP_012468821.1 MNKPMRVTSLLIYLAVLFLCTAAGGCNSNQLPTSGSRSMLATANDLQDKRIAVLQGSTHE MYATRHYPGATVLQYKSVSDMLLALKSGKADAAIYSRDELMEYMRDNDEFGFVGGPLYRT PISIAFHQQDAGLLLSFNRFLQQIRTDGTYDGMLKRWMQQGAVGMPKLTAAGTGKPLVVG ILSDNGLPFIVMKENRLIGFNIELMERFGAFCNRSIKYADIEFGSQIAALAGHKIDMIAT PLAITEERKKRVAFSAPYYTVDSLAFALKKNIATNKSLTPSAPSFLSKLVTSFQSNIIHE RRYLLILDGLKTTVVISVFATLFGTLLGALICFMRMAKSRLLSAPARLYIAILRGTPVLV LLMLIFYVVFASININPVIVAVIAFGMNFGAYTAEIFRTGIEGVEKGQTEAGISLGFTRT STFLHIVLPQMVRRILPVYKGEFISLVKMTSIVGYIAVQDLTKASDIIRSRTFDAFFPLV MVAILYFLISWTLMQSLEYLERITDPKYKKRKAGR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server